Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers - PubMed
Review
Long Noncoding RNAs as Innovative Urinary Diagnostic Biomarkers
Giulia Brisotto et al. Methods Mol Biol. 2021.
Abstract
The characterization of circulating tumor cells (CTCs) is now widely studied as a promising source of cancer-derived biomarkers because of their role in tumor formation and progression. However, CTCs analysis presents some limitations and no standardized method for CTCs isolation from urine has been defined so far. In fact, besides blood, urine represents an ideal source of noninvasive biomarkers, especially for the early detection of genitourinary tumors. Besides CTCs, long noncoding RNAs (lncRNAs) have also been proposed as potential noninvasive biomarkers, and the evaluation of the diagnostic accuracy of urinary lncRNAs has dramatically increased over the last years, with many studies being published. Therefore, this review provides an update on the clinical utility of urinary lncRNAs as novel biomarkers for the diagnosis of bladder and prostate cancers.
Keywords: Bladder cancer; Diagnostic biomarkers; Long noncoding RNAs; Prostate cancer.
Similar articles
-
Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES, Böttcher R, Croce CM, Jenster G, Visakorpi T, Calin GA. Martens-Uzunova ES, et al. Eur Urol. 2014 Jun;65(6):1140-51. doi: 10.1016/j.eururo.2013.12.003. Epub 2013 Dec 14. Eur Urol. 2014. PMID: 24373479 Review.
-
Terracciano D, Ferro M, Terreri S, Lucarelli G, D'Elia C, Musi G, de Cobelli O, Mirone V, Cimmino A. Terracciano D, et al. Transl Res. 2017 Jun;184:108-117. doi: 10.1016/j.trsl.2017.03.005. Epub 2017 Apr 7. Transl Res. 2017. PMID: 28438520 Review.
-
Ghorbanmehr N, Gharbi S, Korsching E, Tavallaei M, Einollahi B, Mowla SJ. Ghorbanmehr N, et al. Prostate. 2019 Jan;79(1):88-95. doi: 10.1002/pros.23714. Epub 2018 Sep 7. Prostate. 2019. PMID: 30194772
-
Urine microRNAs as potential noninvasive biomarkers in urologic cancers.
Mlcochova H, Hezova R, Stanik M, Slaby O. Mlcochova H, et al. Urol Oncol. 2014 Jan;32(1):41.e1-9. doi: 10.1016/j.urolonc.2013.04.011. Epub 2013 Sep 10. Urol Oncol. 2014. PMID: 24035473 Review.
-
Du L, Duan W, Jiang X, Zhao L, Li J, Wang R, Yan S, Xie Y, Yan K, Wang Q, Wang L, Yang Y, Wang C. Du L, et al. J Cell Mol Med. 2018 May;22(5):2838-2845. doi: 10.1111/jcmm.13578. Epub 2018 Mar 8. J Cell Mol Med. 2018. PMID: 29516641 Free PMC article.
Cited by
-
Sweef O, Mahfouz R, Taşcıoğlu T, Albowaidey A, Abdelmonem M, Asfar M, Zaabout E, Corcino YL, Thomas V, Choi ES, Furuta S. Sweef O, et al. Int J Mol Sci. 2024 Aug 19;25(16):9001. doi: 10.3390/ijms25169001. Int J Mol Sci. 2024. PMID: 39201688 Free PMC article. Review.
-
Wang Z, Zhang M, Fu Y. Wang Z, et al. Anatol J Cardiol. 2023 Mar;27(3):167-172. doi: 10.14744/AnatolJCardiol.2022.2496. Anatol J Cardiol. 2023. PMID: 36856591 Free PMC article.
-
Long non-coding RNAs in oncourology.
Gareev I, Gileva Y, Dzidzaria A, Beylerli O, Pavlov V, Agaverdiev M, Mazorov B, Biganyakov I, Vardikyan A, Jin M, Ahmad A. Gareev I, et al. Noncoding RNA Res. 2021 Aug 26;6(3):139-145. doi: 10.1016/j.ncrna.2021.08.001. eCollection 2021 Sep. Noncoding RNA Res. 2021. PMID: 34504983 Free PMC article. Review.
References
-
- Perakis S, Speicher MR (2017) Emerging concepts in liquid biopsies. BMC Med 15(1):75. https://doi.org/10.1186/s12916-017-0840-6 - DOI - PubMed - PMC
-
- Arneth B (2018) Update on the types and usage of liquid biopsies in the clinical setting: a systematic review. BMC Cancer 18(1):527. https://doi.org/10.1186/s12885-018-4433-3 - DOI - PubMed - PMC
-
- Bratulic S, Gatto F, Nielsen J (2019) The translational status of cancer liquid biopsies. Regen Eng Transl Med. https://doi.org/10.1007/s40883-019-00141-2
-
- Castro-Giner F, Gkountela S, Donato C, Alborelli I, Quagliata L, Ng CKY, Piscuoglio S, Aceto N (2018) Cancer diagnosis using a liquid biopsy: challenges and expectations. Diagnostics (Basel, Switzerland) 8(2):31. https://doi.org/10.3390/diagnostics8020031 - DOI
-
- Ferreira MM, Ramani VC, Jeffrey SS (2016) Circulating tumor cell technologies. Mol Oncol 10(3):374–394. https://doi.org/10.1016/j.molonc.2016.01.007 - DOI - PubMed - PMC
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical